Delivery Order HHSN268201600012I-75N92018F00007

Award Date 9/14/18
Potential Completion Date 9/13/19
Potential Value $185K
Ultimate Awardee
University Of Miami
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Cost No Fee
Place of Performance
South Miami, FL 33146, USA
Solicitation Procedures
Multiple Award, Fair Opportunity
Number Of Offers Received
4
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a $154,494.31 cost-reimbursement delivery order awarded by the National Heart Lung and Blood Institute (NHLBI) to the University of Miami for production assistance for cellular therapies (PACT) - cell processing facilities. The contract is part of the larger PACT-CPF program, which provides cell manufacturing and process development services. The University of Miami, a private non-profit research university, will be performing the work in South Miami, Florida. This delivery order does...
The University of Miami Office of Research Administration - School of Medicine Division, doing business as University of Miami-Medical Research Administration, has been awarded a $303,060.30 delivery order against the Production Assistance for Cellular Therapies - Cell Processing Facilities master IDIQ contract held by the National Institutes of Health National Heart Lung and Blood Institute. The order, PCT0004-02, is for improving cellular therapy product quality and will be performed in...
This federal contract award is for the Production Assistance for Cellular Therapies (PACT) - Cell Processing Facilities project, with the National Heart Lung and Blood Institute as the funding agency. The prime contractor is the University of Miami, a private non-profit research university that conducts a wide range of biomedical and healthcare research funded by federal agencies. The $1,016,451.61 contract provides cell manufacturing and process development services for induced pluripotent stem...
The National Heart Lung and Blood Institute (NHLBI), a civilian agency within the U.S. Department of Health and Human Services, awarded a $1,180,889.00 firm-fixed-price delivery order contract to the University of Miami Office of Research Administration - School of Medicine Division for "Production Assistance for Cellular Therapies (PACT) - Cell Processing Facilities". This delivery order is part of a larger PACT-CPF Indefinite Delivery Contract vehicle held by the University of Miami....
This federal contract award is for "PRODUCTION ASSISTANCE FOR CELLULAR THERAPIES (PACT) - CELL PROCESSING FACILITIES CELL MANUFACTURING AND PROCESS DEVELOPMENT SERVICES FOR PCT0005-02: CRYOPRESERVATION TECHNICAL STUDY" through a Delivery Order under the larger "Production Assistance for Cellular Therapies - Cell Processing Facilities (PACT-CPF)" contract vehicle. The prime contractor is the University of Miami, a private non-profit research university, and the contract is...
The Department of Health and Human Services' National Institutes of Health's National Heart Lung and Blood Institute awarded a $156,290 delivery order against the Production Assistance for Cellular Therapies - Cell Processing Facilities indefinite-delivery/indefinite-quantity contract vehicle. The Regents of the University of Minnesota, doing business as the Office of Sponsored Projects Administration, will provide cell manufacturing and process development services as part of the LOVO PACT...
This is a delivery order awarded by the Department of Health and Human Services' National Institutes of Health National Heart Lung and Blood Institute to the University of Miami, a private non-profit university, for $305,761.68 to SCALE UP PROCESSES FOR MSC DERIVED EXOSOMES. The award is part of the Production Assistance for Cellular Therapies - Cell Processing Facilities (PACT-CPF) indefinite delivery/indefinite quantity (IDIQ) contract. No set-aside designation was used. The University of...
This is a federal delivery order contract awarded by the Department of Health and Human Services' National Institutes of Health National Heart Lung and Blood Institute to the University of Miami. The contract, valued at $758,014.97, is for the provision of Wharton's jelly-derived mesenchymal stromal cells (MSCs) to support research on bronchopulmonary dysplasia (BPD). The contract is issued as a delivery order under the larger Production Assistance for Cellular Therapies - Cell Processing...
This is a delivery order awarded by the National Heart Lung and Blood Institute (NHLBI), a component of the National Institutes of Health (NIH), to H. Lee Moffitt Cancer Center and Research Institute Hospital, Inc. (Moffitt Cancer Center), a nonprofit cancer center in Tampa, Florida. The order is for "PRODUCTION ASSISTANCE FOR CELLULAR THERAPIES (PACT)- CELL PROCESSING FACILITIES CELL MANUFACTURING AND PROCESS DEVELOPMENT SERVICES FOR RSA PCT0002-02: LOVO PACT CENTER STUDY" and is part...
This is a federal contract award to H. Lee Moffitt Cancer Center and Research Institute Hospital, Inc. (Moffitt Cancer Center), a nonprofit, National Cancer Institute-designated comprehensive cancer center located in Tampa, Florida. The contract, valued at $761,385.23, is for PRODUCTION ASSISTANCE FOR CELLULAR THERAPIES (PACT)- CELL PROCESSING FACILITIES CELL MANUFACTURING AND PROCESS DEVELOPMENT SERVICES FOR PCT0025-01: FVIII TCR-ENGINEERED TREG CELL PRODUCT. The contract was awarded by the...

This cost-no-fee delivery order, valued at $185,000, was awarded by the National Heart, Lung and Blood Institute of the National Institutes of Health within the Department of Health and Human Services to the University of Miami Office of Research Administration - School of Medicine Division for cell processing facilities cell manufacturing and process development services in support of the Production Assistance for Cellular Therapies (PACT) Center Study LOVO PACT. The award is issued against the PACT-CPF multiple award indefinite-delivery/indefinite-quantity contract to provide cellular therapies cell manufacturing and process development assistance. Performance will take place in South Miami, Florida through September 2019. The prime contractor will utilize its expertise and facilities to support the National Institutes of Health's efforts to advance regenerative medicine research.

Generated 12/30/23, 9:52 AM